Ni Zeng Selected Research

Melanoma (Melanoma, Malignant)

1/2022	Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
1/2022	Characterization of Aging-Related Genes to Predict Prognosis and Evaluate the Tumor Immune Microenvironment in Malignant Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ni Zeng Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 12/2011
9	Inflammation (Inflammations) 04/2024 - 12/2017
9	Fibrosis (Cirrhosis) 02/2024 - 01/2015
7	Sepsis (Septicemia) 04/2024 - 01/2017
5	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2016
4	Cardiomegaly (Heart Hypertrophy) 12/2021 - 01/2020
4	Pleural Effusion (Pleural Effusions) 01/2019 - 04/2017
3	Arthritis (Polyarthritis) 04/2024 - 12/2015
3	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2023
3	Insulin Resistance 01/2022 - 01/2019
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 10/2018
3	Infections 01/2021 - 10/2018
3	Acute Lung Injury 01/2021 - 10/2018
3	Lung Injury 01/2021 - 10/2018
3	Malignant Pleural Effusion 08/2017 - 04/2017
2	Obesity 04/2024 - 12/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2024 - 01/2019
2	Cleft Lip (Harelip) 02/2024 - 01/2021
2	Nasopharyngeal Carcinoma 12/2023 - 01/2023
2	Triple Negative Breast Neoplasms 12/2023 - 01/2020
2	Wounds and Injuries (Trauma) 11/2023 - 06/2021
2	Hypoxia (Hypoxemia) 01/2023 - 01/2021
2	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2022
2	Fatty Liver 01/2021 - 05/2010
2	Non-alcoholic Fatty Liver Disease 01/2021 - 10/2018
2	Pneumonia (Pneumonitis) 11/2018 - 10/2018
2	Liver Diseases (Liver Disease) 02/2018 - 01/2017
2	Septic Shock (Toxic Shock Syndrome) 11/2017 - 01/2017
2	Adenocarcinoma 01/2017 - 01/2016
2	Pulmonary Alveolar Proteinosis 12/2014 - 07/2014
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024
1	Bites and Stings (Sting) 12/2023
1	Edema (Dropsy) 12/2023
1	Necrosis 12/2023
1	Anterior Cruciate Ligament Injuries 11/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023
1	Bronchopulmonary Dysplasia 07/2023
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Pathologic Constriction (Stenosis) 01/2023

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2013
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2014
4	CollagenIBA 12/2023 - 01/2019
4	AntigensIBA 02/2022 - 08/2011
4	SmokeIBA 01/2021 - 11/2015
4	TensinsIBA 01/2021 - 05/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
4	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2021 - 05/2010
3	AntioxidantsIBA 12/2023 - 01/2019
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2023 - 01/2017
3	LipidsIBA 12/2022 - 12/2014
3	Insulin (Novolin)FDA Link 01/2022 - 01/2019
3	MicroRNAs (MicroRNA)IBA 12/2021 - 02/2018
3	Peptides (Polypeptides)IBA 01/2021 - 11/2018
3	Circular RNAIBA 01/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 04/2024 - 01/2019
2	CytokinesIBA 01/2023 - 01/2020
2	FlavonoidsIBA 11/2022 - 11/2018
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2022
2	LipopolysaccharidesIBA 01/2021 - 10/2018
2	EpitopesIBA 01/2021 - 08/2011
2	morinIBA 11/2018 - 12/2015
2	InterleukinsIBA 10/2018 - 12/2017
2	Tumor Biomarkers (Tumor Markers)IBA 08/2017 - 04/2017
2	antigen CYFRA21.1IBA 08/2017 - 04/2017
2	Carcinoembryonic AntigenIBA 08/2017 - 04/2017
2	CalciumIBA 01/2017 - 11/2015
2	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2014 - 07/2014
1	NexusIBA 01/2024
1	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 12/2023
1	DiterpenesIBA 12/2023
1	GlucosidasesIBA 12/2023
1	ManganeseIBA 12/2023
1	Carbon MonoxideIBA 12/2023
1	Coloring Agents (Dyes)IBA 12/2023
1	InterferonsIBA 12/2023
1	Interferon Type IIBA 12/2023
1	Actins (F Actin)IBA 12/2023
1	Matrix Metalloproteinases (MMPs)IBA 12/2023
1	Amino Acids FDA Link 11/2023
1	trastuzumab deruxtecanIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	toripalimabIBA 01/2023
1	CopperIBA 01/2023
1	Chelating AgentsIBA 01/2023

Therapy/Procedure

9	Therapeutics 12/2023 - 01/2017
4	Immunotherapy 12/2023 - 01/2022
4	Ligation 12/2023 - 01/2017
3	Punctures 12/2023 - 01/2017
2	Radiotherapy 12/2023 - 10/2023
1	Oral Medicine 02/2024
1	Photothermal Therapy 12/2023
1	Re-Irradiation 10/2023
1	Renal Dialysis (Hemodialysis) 01/2023
1	Transjugular Intrahepatic Portasystemic Shunt 01/2023
1	Drug Therapy (Chemotherapy) 01/2023